Apogee Therapeutics (NasdaqGM:APGE) Update / Briefing Transcript

Apogee Therapeutics (NasdaqGM:APGE) Update / Briefing January 06, 2026 08:00 AM ET Company ParticipantsDavid Nierengarten - Managing Director of Equity ResearchMichael Henderson - CEOMario Castro - Chief of Pulmonary Critical Care and Sleep Medicine DivisionNoel Kurdi - VP of Investor RelationsCarl Dambkowski - Chief Medical OfficerJeff Hartness - Chief Commercial OfficerAlex Thompson - Managing Director of BiotechnologyPhoebe Tan - Senior Biotechnology Equity Research AssociateDavid Huang - VP of Equity Re ...